- Home
- CGTX vs HUIZ Comparison
CGTX vs HUIZ Comparison
Compare CGTX & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- HUIZ
- Stock Information
- Founded
- CGTX 2007
- HUIZ 2006
- Country
- CGTX United States
- HUIZ China
- Employees
- CGTX N/A
- HUIZ N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- HUIZ Specialty Insurers
- Sector
- CGTX Health Care
- HUIZ Finance
- Exchange
- CGTX Nasdaq
- HUIZ Nasdaq
- Market Cap
- CGTX 20.5M
- HUIZ 18.8M
- IPO Year
- CGTX 2021
- HUIZ 2020
- Fundamental
- Price
- CGTX $0.32
- HUIZ $2.02
- Analyst Decision
- CGTX Strong Buy
- HUIZ
- Analyst Count
- CGTX 5
- HUIZ 0
- Target Price
- CGTX $5.63
- HUIZ N/A
- AVG Volume (30 Days)
- CGTX 1.7M
- HUIZ 31.0K
- Earning Date
- CGTX 05-07-2025
- HUIZ 06-06-2025
- Dividend Yield
- CGTX N/A
- HUIZ N/A
- EPS Growth
- CGTX N/A
- HUIZ N/A
- EPS
- CGTX N/A
- HUIZ N/A
- Revenue
- CGTX N/A
- HUIZ $171,105,205.00
- Revenue This Year
- CGTX N/A
- HUIZ $6.81
- Revenue Next Year
- CGTX N/A
- HUIZ $9.30
- P/E Ratio
- CGTX N/A
- HUIZ N/A
- Revenue Growth
- CGTX N/A
- HUIZ 4.46
- 52 Week Low
- CGTX $0.22
- HUIZ $1.50
- 52 Week High
- CGTX $2.54
- HUIZ $10.58
- Technical
- Relative Strength Index (RSI)
- CGTX 47.90
- HUIZ 43.83
- Support Level
- CGTX $0.24
- HUIZ $2.01
- Resistance Level
- CGTX $0.34
- HUIZ $2.10
- Average True Range (ATR)
- CGTX 0.03
- HUIZ 0.15
- MACD
- CGTX -0.00
- HUIZ -0.00
- Stochastic Oscillator
- CGTX 68.84
- HUIZ 12.09
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.